Kera Capital Partners, Inc.
Position in PHAT — Phathom Pharmaceuticals, Inc.
CIK 2040353
SACRAMENTO, CA
Position in PHAT
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$298,036
-$104,354 QoQ
Shares Held
26,826
+10.6% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PHAT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Kera Capital Partners, Inc. holds $3,712,879 across 11 Biotechnology names. PHAT ranks #5 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KYTX |
Kyverna Therapeutics, Inc.
|
108,083 | $932,756 | |
| 2 | INCY |
Incyte Corp
|
6,755 | $635,780 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
593 | $458,175 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,165 | $409,293 | |
| 5 | PHAT |
Phathom Pharmaceuticals, Inc.
This page
|
26,826 | $298,036 | |
| 6 | TECH |
BIO-TECHNE Corp
|
4,679 | $244,524 | |
| 7 | ALMS |
Alumis Inc.
|
11,003 | $242,396 | |
| 8 | FDMT |
4D Molecular Therapeutics, Inc.
|
24,068 | $224,073 |
All Filings in PHAT
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $298,036 | 26,826 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $402,390 | 24,255 | Shares | Sole | 2026-02-23 | |
| 2025-09-30 | $353,794 | 30,059 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $288,265 | 30,059 | Shares | Sole | 2025-07-01 | |
| 2025-03-31 | $187,153 | 29,849 | Shares | Sole | 2025-04-02 | |
| 2024-12-31 | $218,013 | 26,849 | Shares | Sole | 2025-01-15 | |
| No filing history on record for this holder in this stock. | ||||||